Sunday, September 27, 2026

IBOVESPA Went Up By Over 8% In The Last 21 Sessions

IBOVESPA Went Up By Over 8% In The Last 21 Sessions

(VIANEWS) - IBOVESPA (BVSP) has been up by 8.03% for the last 21 sessions. At 10:11 EST on Thursday, 22 June, IBOVESPA (BVSP) is $118,757.38.

Concerning IBOVESPA's yearly highs and lows, it's 24.66% up from its 52-week low and 1.65% down from its 52-week high.

Volatility

IBOVESPA's last week, last month's, and last quarter's current intraday variation average was 0.25%, 0.43%, and 0.93%, respectively.

IBOVESPA's highest amplitude of average volatility was 0.55% (last week), 0.88% (last month), and 0.93% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IBOVESPA's is considered to be oversold (<=20).

News about

  • According to MarketWatch on Tuesday, 20 June, "BD stock is up 1.7% in 2023, while Steris stock is up 15.7% so far this year, compared to a 14.9% increase by the S&P 500 ."
  • According to Zacks on Tuesday, 20 June, "On the weekly chart, the S&P 500 Index is running into the 1.618 extension level from the February correction.", "In the short -term, the S&P 500 Index is approaching a critical "confluence level". "
  • According to MarketWatch on Tuesday, 20 June, "NiSource's stock has slipped 0.2% year to date through Friday while Blackstone shaves have climbed 22.8% and the S&P 500 has advanced 14.9%."
  • According to MarketWatch on Tuesday, 20 June, "On Friday, the Dow Jones Industrial Average fell 109 points, or 0.32%, to 34299, the S&P 500 declined 16 points, or 0.37%, to 4410, and the Nasdaq Composite dropped 93 points, or 0.68%, to 13690.", "The S&P 500 gained 2.6% last week, its fifth week in a row of gains, as the tech-heavy Nasdaq Composite took its winning run to eight weeks."

More news about IBOVESPA (BVSP).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com